Suchergebnisse - "Pinato, David J"

PubPharm (6)

1

Comparative efficacy of novel combination strategies for unresectable hepatocellular carcinoma : A network metanalysis of phase III trials

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Fulgenzi, C. | D'Alessio, A. | Airoldi, C. | +5

2

Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma : evaluation of safety and efficacy in a retrospective, propensity score-matched study

enthalten in: Journal for immunotherapy of cancer | 2022

von Marinelli, B. | Kim, E. | D'Alessio, A. | +23

3

PRIME-HCC : phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma

enthalten in: BMC cancer | 2021

von Pinato, D. | Cortellini, A. | Sukumaran, A. | +14

4

Post-registration experience of nivolumab in advanced hepatocellular carcinoma : an international study

enthalten in: Journal for immunotherapy of cancer | 2020

von Fessas, P. | Kaseb, A. | Wang, Y. | +24

5

Antibiotic Treatment and Immune Checkpoint Inhibitor Therapy in Patients With Cancer-Reply

enthalten in: JAMA oncology | 2020

von Pinato, D. | Newsom-Davis, T. | Bower, M.

CommentOn: JAMA Oncol. 2019 Dec 1;5(12):1774-1778. - PMID 31513236

6

PD-L1 expressing granulomatous reaction as an on-target mechanism of steroid-refractory immune hepatotoxicity

enthalten in: Immunotherapy | 2019

von Black, J. | Goldin, R. | Foxton, M. | +6

1
[1]